Correlation Between Rxsight and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rxsight and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rxsight and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rxsight and Neuropace, you can compare the effects of market volatilities on Rxsight and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rxsight with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rxsight and Neuropace.

Diversification Opportunities for Rxsight and Neuropace

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Rxsight and Neuropace is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Rxsight and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Rxsight is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rxsight are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Rxsight i.e., Rxsight and Neuropace go up and down completely randomly.

Pair Corralation between Rxsight and Neuropace

Given the investment horizon of 90 days Rxsight is expected to generate 1.82 times less return on investment than Neuropace. But when comparing it to its historical volatility, Rxsight is 1.83 times less risky than Neuropace. It trades about 0.1 of its potential returns per unit of risk. Neuropace is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  163.00  in Neuropace on August 31, 2024 and sell it today you would earn a total of  897.00  from holding Neuropace or generate 550.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Rxsight  vs.  Neuropace

 Performance 
       Timeline  
Rxsight 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rxsight has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Neuropace 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Rxsight and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rxsight and Neuropace

The main advantage of trading using opposite Rxsight and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rxsight position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind Rxsight and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data